The purpose of this paper was to determine the effects of preservation method and detection method on quantification of deoxyadenosine (dA)-aristolactam (AL-I) adducts in upper urinary tract cancer specimens.
Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.
Yun BH, Rosenquist TA, Nikolić J, Dragičević D, Tomić K, Jelaković B, Dickman KG, Grollman AP, Turesky RJ
Purpose
Conclusion
When analyzed by liquid chromatography mass-spectrometry (LC-MS), frozen and FFPE specimens had comparable levels of dA-AL-I adducts. For frozen specimens (FFPE was not investigated), the quantification of dA-AL-I adducts by LC-MS was comparable to that quantified by radioassay, but LC-MS was more sensitive.
Studies (1)
Purpose
The purpose of this study was to determine the effects of preservation method and detection method on quantification of dA-AL-I adducts in upper urinary tract cancer specimens. 5 specimens were immediately frozen at -80°C or fixed for 24 h in formalin. FFPE blocks were stored at room temperature. DNA was extracted from frozen specimens using a phenol-chloroform based method and from FFPE specimens using a modification of the ZR FFPE DNA MiniPrep kit.
Summary of Findings
dA-AL-I adduct levels measured by LC-MS were comparable in frozen (0.13-7.0) and FFPE specimens (0.48-6.2). For frozen specimens (FFPE was not investigated), the levels of dA-AL-I adducts measured by LC-MS were comparable to those measured by radioassay, but LC-MS was more sensitive.
Biospecimens
TissueKidneyPreservation Types
FrozenFormalinDiagnoses
NeoplasticCarcinomaPlatforms
DNALC-ESI-MS/MSDNARadioassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation Formalin (buffered)FrozenLC-ESI-MS/MS Specific Technology platform Radioassay